By: Stephanie Brown From: medicalxpress.com The U.S. Food and Drug Administration has granted de novo authorization to CLAIRITY BREAST, a first-in-class, image-based platform that can help predict a woman’s risk for breast cancer. CLAIRITY BREAST is designed as a prognostic tool that can predict the five-year risk of developing breast cancer by analyzing subtle imaging features on routine mammograms, making …
-
-
What Motivates You to Action After a Breast Cancer Diagnosis?
-
The 4th of July – Independence Day for This Breast Cancer Survivor
-
What Is Needed After Breast Cancer Surgery?
-
The Sadness Experienced by Some Breast Cancer Survivors
-
The Importance of Hope for Breast Cancer Survivors
